Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses
Abstract Despite decades of research very few vaccine-adjuvants have received FDA approval. Two fundamental challenges plague clinical translation of vaccine-adjuvants: reducing acute toxicities that result from systemic diffusion of many soluble adjuvants, and delivering multiple adjuvants at the s...
Main Authors: | Ranjna Madan-Lala, Pallab Pradhan, Krishnendu Roy |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-02804-y |
Similar Items
-
Biophysical Attributes of CpG Presentation Control TLR9 Signaling to Differentially Polarize Systemic Immune Responses
by: Jardin A. Leleux, et al.
Published: (2017-01-01) -
Polymeric Core–Shell Combinatorial Nanomedicine for Synergistic Anticancer Therapy
by: Asifkhan Shanavas, et al.
Published: (2019-11-01) -
Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
by: Caterina Cascini, et al.
Published: (2023-06-01) -
Modulation of Innate Immune Responses via Covalently Linked TLR Agonists
by: Janine K. Tom, et al.
Published: (2015-10-01) -
Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV
by: A.B. Macedo, et al.
Published: (2017-12-01)